C4 Therapeutics (CCCC) Balance Sheet: Assets & Liabilities

C4 Therapeutics (CCCC) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), C4 Therapeutics reported total assets of $359.07M and total liabilities of $102.49M. Shareholders' equity was $256.59M, up 18.8% from $215.99M a year earlier. Total debt stood at $59.98M against $248.54M in cash and short-term investments, a net cash position of $188.56M. That puts debt-to-equity at 0.23, compared with 0.30 a year earlier.

C4 Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for C4 Therapeutics, Inc. (CCCC) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	74.60	55.50	126.59	29.75	76.12	181.73	90.55	36.31
Short-Term Investments	173.93	189.41	127.09	246.40	233.16	189.96	0.00	0.00
Cash & Short-Term Investments	248.54	244.90	253.68	276.15	309.28	371.69	90.55	36.31
Accounts Receivable	2.40	3.10	11.80	1.47	5.72	4.48	4.62	86.44
Inventory	0.00	0.00	0.00	-60.96	0.00	0.00	0.00	0.00
Other Current Assets	7.17	9.76	5.71	70.89	10.69	4.84	1.60	0.78
Total Current Assets	258.11	257.77	271.19	287.56	325.69	381.01	96.77	123.53
Non-Current Assets
Property, Plant & Equipment (Net)	45.28	63.38	71.09	77.52	35.05	16.55	18.92	20.38
Long-Term Investments	48.56	22.36	28.01	60.96	142.20	0.00	0.00	2.58
Other Non-Current Assets	7.13	6.10	6.17	4.81	3.82	2.58	2.58	0.00
Total Non-Current Assets	100.97	91.84	105.26	143.28	181.08	19.13	21.49	22.96
Total Assets	359.08	349.60	376.45	430.84	506.77	400.14	118.26	146.49
Current Liabilities
Accounts Payable	0.86	1.33	1.45	1.17	4.51	5.68	5.39	1.15
Short-Term Debt	6.37	5.77	10.44	6.99	1.33	1.04	0.88	0.73
Current Portion of Long-Term Debt	-	-	-	2.29	-	-	-	-
Accrued Liabilities	3.26	19.36	11.24	19.77	13.61	9.52	-	-
Deferred Revenue	12.49	18.71	15.47	16.62	31.80	27.60	20.71	19.11
Other Current Liabilities	13.31	1.87	2.04	19.77	13.61	0.47	6.67	2.95
Total Current Liabilities	33.03	45.18	42.77	44.55	51.25	43.85	33.64	23.95
Non-Current Liabilities
Long-Term Debt	53.62	59.98	65.76	80.17	41.55	10.05	12.87	13.75
Deferred Tax Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-13.75
Other Non-Current Liabilities	0.00	28.46	0.00	0.00	0.00	53.62	111.00	111.00
Total Non-Current Liabilities	69.46	88.44	87.57	97.06	65.91	75.50	196.58	202.29
Total Liabilities	102.49	133.62	130.34	141.61	117.16	119.35	230.22	226.24
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00
Retained Earnings	-738.69	-633.70	-528.38	-395.89	-267.72	-183.82	-117.49	-83.39
Accumulated Other Comprehensive Income	0.05	0.05	-0.13	-4.14	-0.78	0.01	0.00	-2.50
Additional Paid-in Capital	995.22	849.63	774.62	689.26	658.09	464.60	-105.47	-113.50
Shares Outstanding	96.91	70.63	60.47	48.97	48.69	-	-	-
Total Stockholders' Equity	256.59	215.99	246.11	289.23	389.61	280.79	-111.96	-79.75
Total Liabilities & Equity	359.08	349.60	376.45	430.84	506.77	400.14	118.26	146.49

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About C4 Therapeutics Balance Sheet

How much debt does C4 Therapeutics have?

C4 Therapeutics had total debt of $59.98M as of Dec 31, 2025, against $248.54M in cash and short-term investments. Its debt-to-equity ratio was 0.23. Total debt was $65.76M a year earlier.

What are C4 Therapeutics's total assets?

C4 Therapeutics reported total assets of $359.07M as of Dec 31, 2025, up 2.7% from $349.60M a year earlier. Total liabilities were $102.49M.

What is C4 Therapeutics's shareholders' equity?

C4 Therapeutics's shareholders' equity was $256.59M as of Dec 31, 2025, or about $2.65 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition